{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:07:24Z","timestamp":1791418044708,"version":"4.3.3"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11,27]]},"DOI":"10.1097\/tp.0b013e31823328c0","type":"journal-article","created":{"date-parts":[[2011,10,15]],"date-time":"2011-10-15T05:24:58Z","timestamp":1318656298000},"page":"1077-1084","source":"Crossref","is-referenced-by-count":70,"title":["BK Virus-Specific T Cells for Use in Cellular Therapy Show Specificity to Multiple Antigens and Polyfunctional Cytokine Responses"],"prefix":"10.1097","volume":"92","author":[{"given":"Emily","family":"Blyth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leighton","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Simms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivashni","family":"Gaundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"O'Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Micklethwaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210129","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.meegid.2009.04.008","article-title":"Phylogenetics, evolution, and medical importance of polyomaviruses.","volume":"9","author":"Krumbholz","year":"2009","journal-title":"Infect Genet Evol"},{"key":"R2-3-20210129","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1086\/597126","article-title":"Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors.","volume":"199","author":"Egli","year":"2009","journal-title":"J Infect Dis"},{"key":"R3-3-20210129","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jmv.10450","article-title":"Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40.","volume":"71","author":"Knowles","year":"2003","journal-title":"J Med Virol"},{"key":"R4-3-20210129","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.bbmt.2009.04.016","article-title":"BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem cell transplants.","volume":"15","author":"O'Donnell","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"R5-3-20210129","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMoa020439","article-title":"Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients.","volume":"347","author":"Hirsch","year":"2002","journal-title":"N Engl J Med"},{"key":"R6-3-20210129","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1600-6143.2009.02952.x","article-title":"BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results.","volume":"10","author":"Hardinger","year":"2010","journal-title":"Am J Transplant"},{"key":"R7-3-20210129","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/TP.0b013e318197c17d","article-title":"The decade of polyomavirus BK-associated nephropathy: State of affairs.","volume":"87","author":"Ramos","year":"2009","journal-title":"Transplantation"},{"key":"R8-3-20210129","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM199404283301703","article-title":"Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.","volume":"330","author":"Papadopoulos","year":"1994","journal-title":"N Engl J Med"},{"key":"R9-3-20210129","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bcmd.2007.06.020","article-title":"T cell therapy of Epstein-Barr virus and adenovirus infections after hemopoietic stem cell transplant.","volume":"40","author":"Comoli","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"R10-3-20210129","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood-2009-08-239186","article-title":"Long term outcome of EBV specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients.","volume":"115","author":"Heslop","year":"2010","journal-title":"Blood"},{"key":"R11-3-20210129","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1182\/blood-2008-06-161695","article-title":"Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation.","volume":"112","author":"Micklethwaite","year":"2008","journal-title":"Blood"},{"key":"R12-3-20210129","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbmt.2007.02.004","article-title":"Ex-vivo expansion and prophylactic infusion of CMV-pp65 peptide specific cytotoxic T-lymphocytes following allogeneic haemopoietic stem cell transplantation.","volume":"13","author":"Micklethwaite","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"R13-3-20210129","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: Implications for vaccine design.","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"R14-3-20210129","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1097\/01.ASN.0000096374.08473.E3","article-title":"Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients.","volume":"14","author":"Comoli","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R15-3-20210129","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4049\/jimmunol.174.2.1037","article-title":"Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence.","volume":"174","author":"Harari","year":"2005","journal-title":"J Immunol"},{"key":"R16-3-20210129","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2006-12-063008","article-title":"Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: Results of a phase 2 multicenter clinical trial.","volume":"110","author":"Haque","year":"2007","journal-title":"Blood"},{"key":"R17-3-20210129","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1182\/blood-2010-04-281873","article-title":"Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes.","volume":"116","author":"Barker","year":"2010","journal-title":"Blood"},{"key":"R18-3-20210129","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/bmt.2010.221","article-title":"Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient.","volume":"46","author":"Balduzzi","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"R19-3-20210129","doi-asserted-by":"crossref","first-page":"11170","DOI":"10.1128\/JVI.79.17.11170-11178.2005","article-title":"Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides.","volume":"79","author":"Krymskaya","year":"2005","journal-title":"J Virol"},{"key":"R20-3-20210129","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.virol.2006.02.040","article-title":"Cross-reactive CTL recognizing two HLA-A*02-restricted epitopes within the BK virus and JC virus VP1 polypeptides are frequent in immunocompetent individuals.","volume":"350","author":"Sharma","year":"2006","journal-title":"Virology"},{"key":"R21-3-20210129","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0022-1759(94)90110-4","article-title":"CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity.","volume":"172","author":"Lichtenfels","year":"1994","journal-title":"J Immunol Methods"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0b013e31823328c0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:26:27Z","timestamp":1786047987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-201111270-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,27]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e31823328c0","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11,27]]}}}